Anavex Life Sciences Corp. (Nasdaq: AVXL) is a pioneering biopharmaceutical company based in New York, NY. With a strong focus on the central nervous system (CNS), we are dedicated to discovering and developing targeted treatments for a wide range of neurological conditions.

Our core values, including precision therapeutics, community-based insights, scientific innovation, and inclusion & equitable access, drive us forward in our mission. We believe that by combining cutting-edge research and a deep understanding of patients' needs, we can make a meaningful impact on people's lives. With a team of esteemed experts in the field, including renowned management, directors, and scientific advisors, we are at the forefront of advancements in CNS therapeutics.

Our commitment to transparency and collaboration is reflected in our quick links to resources, allowing easy access to information about our therapeutic candidates, investors, news, careers, and how to get in touch with us. Join us on our journey to revolutionize the treatment of neurological conditions. Together, we can shape a better future for patients worldwide.

Subscribe to our mailing list to stay updated with our latest developments. ANAVEX® – Empowering life through scientific innovation